Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neuroblastoma 1

Interventions

Cyclophosphamide 12 Vincristine 10 Radiotherapy 10 Carboplatin 10 Cisplatin 8 Melphalan 7 Etoposide 7 3-Iodobenzylguanidine 7 Isotretinoin 6 Filgrastim 6 Doxorubicin 6 aldesleukin 4 Peripheral Blood Stem Cell Transplantation 4 Busulfan 4 etoposide phosphate 3 Topotecan 3 Neoadjuvant Therapy 3 Interleukin-2 3 Ifosfamide 3 fludarabine 2 dinutuximab 2 Vindesine 2 Polymerase Chain Reaction 2 Granulocyte-Macrophage Colony-Stimulating Factor 2 Dacarbazine 2 Chemotherapy, Adjuvant 2 sargramostim 1 irinotecan sucrosofate 1 ganglioside, GD2 1 fludarabine phosphate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Neuroblastoma × Vaccines, DNA × Clear all

NCT04049864 2022-03-02

DNA Vaccination Against Neuroblastoma

Belarusian Research Center for Pediatric Oncology, Hematology and Immunology

Phase EARLY_PHASE1 Unknown

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡